Nature Medicine
Semaglutide improved heart filling in obesity-related heart failure
Semaglutide improved how much the heart’s upper left chamber stretched by 5.7 percentage points versus placebo over 52 weeks in a 49-person trial substudy.Semaglutide improved how much the heart’s upper left chamber stretched by 5.7 percentage points versus placebo over 52 weeks in a 49-person trial substudy.
Randomized trial · 49 peopleSemaglutide
Who was studied49 patients with obesity-related HFpEF, 52 weeks, against placebo
What changedThe heart’s upper left chamber stretched 5.7 percentage points more with semaglutide than placebo over 52 weeks
The catchOnly 49 participants had heart scans, with 16 receiving placebo
